Letibotulinum Toxin A vs Onabotulinum Toxin A for the Treatment of Crow's Feet
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized, Double-Blind, Active-Controlled, Multicentre, Phase III Clinical Trial With Two Stages to Assess the Safety and Efficacy of Letibotulinum Toxin A vs. Onabotulinum Toxin A for Subjects With Moderate to Severe Crow's Feet
J Eur Acad Dermatol Venereol 2021 Mar 15;[EPub Ahead of Print], KH Yoo, SJ Park, HS Han, CH Won, YW Lee, BJ KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.